甲磺酸帕罗西汀（CAS 217797-14-3）：分子式 C20H24FNO6S、分子量 425.5。
| CAS号 | 217797-14-3 |
|---|---|
| 分子式 | C20H24FNO6S |
| 分子量 | 425.5 |
| 应用领域 | Uses: Labeled indications include: major depressive disorder (MDD)、panic disorder with or without agoraphobia、obsessive-compulsive disorder (OCD)、social anxiety disorder (social phobia)、generalized anxiety disorder (GAD)、post-traumatic stress disorder (PTSD)、and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders、impulse control disorders、vasomotor symptoms of menopause、obsessive-compulsive disorder (OCD) in children、and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle、which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause. |
登记用途：Uses: Labeled indications include: major depressive disorder (MDD)、panic disorder with or without agoraphobia、obsessive-compulsive disorder (OCD)、social anxiety disorder (social phobia)、generalized anxiety disorder (GAD)、post-traumatic stress disorder (PTSD)、and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders、impulse control disorders、vasomotor symptoms of menopause、obsessive-compulsive disorder (OCD) in children、and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle、which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause.。
甲磺酸帕罗西汀 是一种化工化合物，登记 CAS 号为 217797-14-3，分子式 C20H24FNO6S（分子量 425.5）。
登记 CAS 号：217797-14-3
其分子式 C20H24FNO6S 由 20 个碳、24 个氢、1 个氟、1 个氮、6 个氧、1 个硫 组成。
别名/同义词：甲磺酸帕罗西汀 · Paroxetine Mesylate
甲磺酸帕罗西汀 的 CAS 登记号为 217797-14-3。
分子式 C20H24FNO6S，分子量 425.5。
别名/同义词：甲磺酸帕罗西汀、Paroxetine Mesylate。
登记用途：Uses: Labeled indications include: major depressive disorder (MDD)、panic disorder with or without agoraphobia、obsessive-compulsive disorder (OCD)、social anxiety disorder (social phobia)、generalized anxiety disorder (GAD)、post-traumatic stress disorder (PTSD)、and premenstrual dysphoric disorder (PMDD). Unlabeled indications include: eating disorders、impulse control disorders、vasomotor symptoms of menopause、obsessive-compulsive disorder (OCD) in children、and mild dementia-associated agitation in nonpsychotic individuals. Brisdelle、which consists of paroxetine mesylate is indicated for the treatment of moderate to severe vasomotor symptoms (like hot flashes) associated with menopause.。
甲磺酸帕罗西汀（CAS 217797-14-3）的独立参考数据，整理自公开化学数据库。
| CAS Registry Number | 217797-14-3 |
|---|---|
| PubChem CID | 9845306 |
| Molecular formula | C20H24FNO6S |
| IUPAC name | (3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;methanesulfonic acid |
| UNII (FDA) | M711N184JE |
| Molecular Weight | 425.5 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 425.13083682 |
| Monoisotopic Mass | 425.13083682 |
| Topological Polar Surface Area | 102 |
| Heavy Atom Count | 29 |
Paroxetine Mesylate; 217797-14-3; Paroxetine Mesilate; POT.mes; Paroxetine methanesulfonate; Brisdelle; Mesafem; Pexeva; Paroxetine methanesulphonate; LDMP; PO-T.MES; M711N184JE; UNII-M711N184JE; (-)-trans-4R-(4'-Fluorophenyl)-3S-((3',4'-methylenedioxyphenoxy)methyl)piperidine, mesylate; Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-, methanesulfonate; PAROXETINE MESILATE (MART.)
| Reported hazard statements | H302 (100%), H336 (50%), H361 (50%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H336 (50%): May cause drowsiness or dizziness [Warning Specific target organ toxicity, single exposure; Narcotic effects]
Paroxetine Mesylate · CAS 217797-14-3 · C20H24FNO6S. UNII M711N184JE.
数据来源：PubChem / Wikidata；与随货 COA 不一致时以 COA 为准。
English page: Paroxetine Mesylate